234 related articles for article (PubMed ID: 23929703)
21. Metallothionein expression is suppressed in primary human hepatocellular carcinomas and is mediated through inactivation of CCAAT/enhancer binding protein alpha by phosphatidylinositol 3-kinase signaling cascade.
Datta J; Majumder S; Kutay H; Motiwala T; Frankel W; Costa R; Cha HC; MacDougald OA; Jacob ST; Ghoshal K
Cancer Res; 2007 Mar; 67(6):2736-46. PubMed ID: 17363595
[TBL] [Abstract][Full Text] [Related]
22. Leptin as a critical regulator of hepatocellular carcinoma development through modulation of human telomerase reverse transcriptase.
Stefanou N; Papanikolaou V; Furukawa Y; Nakamura Y; Tsezou A
BMC Cancer; 2010 Aug; 10():442. PubMed ID: 20723213
[TBL] [Abstract][Full Text] [Related]
23. Upregulation of C/EBPα Inhibits Suppressive Activity of Myeloid Cells and Potentiates Antitumor Response in Mice and Patients with Cancer.
Hashimoto A; Sarker D; Reebye V; Jarvis S; Sodergren MH; Kossenkov A; Sanseviero E; Raulf N; Vasara J; Andrikakou P; Meyer T; Huang KW; Plummer R; Chee CE; Spalding D; Pai M; Khan S; Pinato DJ; Sharma R; Basu B; Palmer D; Ma YT; Evans J; Habib R; Martirosyan A; Elasri N; Reynaud A; Rossi JJ; Cobbold M; Habib NA; Gabrilovich DI
Clin Cancer Res; 2021 Nov; 27(21):5961-5978. PubMed ID: 34407972
[TBL] [Abstract][Full Text] [Related]
24. Adenovirus-mediated transfer of CCAAT/enhancer-binding protein-alpha identifies a dominant antiproliferative role for this isoform in hepatocytes.
Diehl AM; Johns DC; Yang S; Lin H; Yin M; Matelis LA; Lawrence JH
J Biol Chem; 1996 Mar; 271(13):7343-50. PubMed ID: 8631755
[TBL] [Abstract][Full Text] [Related]
25. Bazedoxifene exhibits growth suppressive activity by targeting interleukin-6/glycoprotein 130/signal transducer and activator of transcription 3 signaling in hepatocellular carcinoma.
Ma H; Yan D; Wang Y; Shi W; Liu T; Zhao C; Huo S; Duan J; Tao J; Zhai M; Luo P; Guo J; Tian L; Mageta L; Jou D; Zhang C; Li C; Lin J; Lv J; Li S; Lin L
Cancer Sci; 2019 Mar; 110(3):950-961. PubMed ID: 30648776
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-6 inhibits cell proliferation in a rat model of hepatocellular carcinoma.
Moran DM; Mayes N; Koniaris LG; Cahill PA; McKillop IH
Liver Int; 2005 Apr; 25(2):445-57. PubMed ID: 15780071
[TBL] [Abstract][Full Text] [Related]
27. A hierarchical regulatory network ensures stable albumin transcription under various pathophysiological conditions.
Feng R; Kan K; Sticht C; Li Y; Wang S; Liu H; Shao C; Munker S; Niess H; Wang S; Meyer C; Liebe R; Ebert MP; Dooley S; Ding H; Weng H
Hepatology; 2022 Dec; 76(6):1673-1689. PubMed ID: 35257388
[TBL] [Abstract][Full Text] [Related]
28. Dietary PUFA modulate the expression of proliferation and differentiation markers in Morris 3924A hepatoma cells.
Vecchini A; Ceccarelli V; Nocentini G; Riccardi C; Di Nardo P; Binaglia L
Biochim Biophys Acta; 2005 Dec; 1737(2-3):138-44. PubMed ID: 16290114
[TBL] [Abstract][Full Text] [Related]
29. MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells.
Yu G; Chen X; Chen S; Ye W; Hou K; Liang M
J Transl Med; 2016 May; 14(1):122. PubMed ID: 27150195
[TBL] [Abstract][Full Text] [Related]
30. Tamoxifen induction of CCAAT enhancer-binding protein alpha is required for tamoxifen-induced apoptosis.
Cheng J; Yu DV; Zhou JH; Shapiro DJ
J Biol Chem; 2007 Oct; 282(42):30535-43. PubMed ID: 17716978
[TBL] [Abstract][Full Text] [Related]
31. Sumoylation of CCAAT/enhancer-binding protein alpha and its functional roles in hepatocyte differentiation.
Sato Y; Miyake K; Kaneoka H; Iijima S
J Biol Chem; 2006 Aug; 281(31):21629-21639. PubMed ID: 16735515
[TBL] [Abstract][Full Text] [Related]
32. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
[TBL] [Abstract][Full Text] [Related]
33. C/EBPalpha redirects androgen receptor signaling through a unique bimodal interaction.
Zhang J; Gonit M; Salazar MD; Shatnawi A; Shemshedini L; Trumbly R; Ratnam M
Oncogene; 2010 Feb; 29(5):723-38. PubMed ID: 19901962
[TBL] [Abstract][Full Text] [Related]
34. Expression and sub-cellular localization of the CCAAT/enhancer binding protein alpha in relation to postnatal development and malignancy of the prostate.
Zhang J; Wilkinson JE; Gonit M; Keck R; Selman S; Ratnam M
Prostate; 2008 Aug; 68(11):1206-14. PubMed ID: 18481268
[TBL] [Abstract][Full Text] [Related]
35. Hepcidin is down-regulated in alcoholic liver injury: implications for the pathogenesis of alcoholic liver disease.
Bridle K; Cheung TK; Murphy T; Walters M; Anderson G; Crawford DG; Fletcher LM
Alcohol Clin Exp Res; 2006 Jan; 30(1):106-12. PubMed ID: 16433737
[TBL] [Abstract][Full Text] [Related]
36. Silencing of signal transducer and activator of transcription 3 expression by RNA interference suppresses growth of human hepatocellular carcinoma in tumor-bearing nude mice.
Li J; Piao YF; Jiang Z; Chen L; Sun HB
World J Gastroenterol; 2009 Jun; 15(21):2602-8. PubMed ID: 19496189
[TBL] [Abstract][Full Text] [Related]
37. Identification of C/EBPα as a novel target of the HPV8 E6 protein regulating miR-203 in human keratinocytes.
Marthaler AM; Podgorska M; Feld P; Fingerle A; Knerr-Rupp K; Grässer F; Smola H; Roemer K; Ebert E; Kim YJ; Bohle RM; Müller CSL; Reichrath J; Vogt T; Malejczyk M; Majewski S; Smola S
PLoS Pathog; 2017 Jun; 13(6):e1006406. PubMed ID: 28640877
[TBL] [Abstract][Full Text] [Related]
38. IL-32α down-regulates β2 integrin (CD18) expression by suppressing PU.1 expression in myeloid cells.
Kang JW; Park YS; Kim MS; Lee DH; Bak Y; Ham SY; Song YS; Hong JT; Yoon DY
Cell Signal; 2014 Jul; 26(7):1514-22. PubMed ID: 24703937
[TBL] [Abstract][Full Text] [Related]
39. Targeted Delivery of C/EBPα-saRNA by RNA Aptamers Shows Anti-tumor Effects in a Mouse Model of Advanced PDAC.
Yoon S; Huang KW; Andrikakou P; Vasconcelos D; Swiderski P; Reebye V; Sodergren M; Habib N; Rossi JJ
Mol Ther Nucleic Acids; 2019 Dec; 18():142-154. PubMed ID: 31546149
[TBL] [Abstract][Full Text] [Related]
40. CCAAT/enhancer binding protein α predicts poorer prognosis and prevents energy starvation-induced cell death in hepatocellular carcinoma.
Lu GD; Ang YH; Zhou J; Tamilarasi J; Yan B; Lim YC; Srivastava S; Salto-Tellez M; Hui KM; Shen HM; Nguyen LN; Tan BC; Silver DL; Hooi SC
Hepatology; 2015 Mar; 61(3):965-78. PubMed ID: 25363290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
